TCRX vs XPO · rev $2.0M vs P/E 69, rev $2.35B
Tscan Therapeutics Inc (TCRX) versus XPO Logistics Inc (XPO) — a side-by-side from cached financials, not a winner call.
Tscan Therapeutics Inc (TCRX) is a biotechnology company listed on NASDAQ.
XPO Logistics Inc (XPO) is a trucking company listed on NYSE.
Latest reported TCRX revenue for 2026-06-30 was $2.0M. Net income was -$59.0M. TCRX currently screens at market cap $62.1M.
Latest reported XPO revenue for 2026-06-30 was $2.35B. Net income was $162.0M. Revenue was up 12.4% from 2026-03-31 to 2026-06-30. XPO currently screens at market cap $23.69B and trailing P/E 69.3.
TCRX currently screens at market cap $62.1M. XPO currently screens at market cap $23.69B and trailing P/E 69.3.
Not investment advice. Open the TCRX and XPO stock pages for the full models.
Not investment advice.